These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9353618)

  • 21. Lipoprotein(a) is an independent risk factor for multiple cerebral infarctions.
    Hiraga T; Shimada M; Okubo M; Nakanishi K; Kobayashi T; Murase T
    Atherosclerosis; 1996 Apr; 122(1):29-32. PubMed ID: 8724109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
    Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y
    Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carotid atherosclerosis and serum lipoprotein(a) concentrations in patients with NIDDM.
    Yamamoto M; Egusa G; Yamakido M
    Diabetes Care; 1997 May; 20(5):829-31. PubMed ID: 9135950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
    Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
    ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications.
    Erem C; Değer O; Bostan M; Orem A; Sönmez M; Ulusoy S; Telatar M
    Acta Cardiol; 1999 Aug; 54(4):203-7. PubMed ID: 10511896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance in Fibrocalculous (tropical) pancreatic diabetes.
    Mohan V; Ramachandran A; Vijay Kumar G; Snehalatha C; Viswanathan M
    Horm Metab Res; 1988 Dec; 20(12):746-8. PubMed ID: 3220451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
    Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
    Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study.
    Lim TS; Yun JS; Cha SA; Song KH; Yoo KD; Ahn YB; Park YM; Ko SH
    Korean J Intern Med; 2016 Nov; 31(6):1110-1119. PubMed ID: 27756118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a) concentrations and non-insulin-dependent diabetes mellitus: relationship to glycaemic control and diabetic complications.
    Chico A; Pérez A; Caixàs A; Ordóñez J; Pou JM; de Leiva A
    Diabetes Res Clin Pract; 1996 Jul; 33(2):105-10. PubMed ID: 8879965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein (a) and other risk factors in patients with non-insulin-dependent diabetes mellitus.
    Martínez-Triguero ML; Salvador A; Samper MJ; Almela M; Vega L; Mora A; Martínez-Diago V
    Coron Artery Dis; 1994 Sep; 5(9):755-60. PubMed ID: 7858765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans.
    Liu Y; Cui Y; Zhou Z; Liu B; Liu Z; Li G
    Dis Markers; 2023; 2023():1316821. PubMed ID: 36865500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus.
    Targher G; Alberiche M; Zenere MB; Bonadonna RC; Muggeo M; Bonora E
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3619-24. PubMed ID: 9360516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
    Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are risk factors for conversion to NIDDM similar in high and low risk populations?
    Haffner SM; Miettinen H; Stern MP
    Diabetologia; 1997 Jan; 40(1):62-6. PubMed ID: 9028719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for the development of NIDDM in Yonchon County, Korea.
    Shin CS; Lee HK; Koh CS; Kim YI; Shin YS; Yoo KY; Paik HY; Park YS; Yang BG
    Diabetes Care; 1997 Dec; 20(12):1842-6. PubMed ID: 9405904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects.
    Harano Y; Kageyama A; Nakao Y; Hara Y; Suzuki M; Sato A; Ikebuchi M; Shinozaki K; Tsushima M
    Diabetes; 1996 Jul; 45 Suppl 3():S31-4. PubMed ID: 8674886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
    Mari A
    Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
    Garvey WT; Olefsky JM; Rubenstein AH; Kolterman OG
    Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.